biomarker

How’s my driving? GPS tracking spots Alzheimer’s with 86% accuracy

Diagnosing Alzheimer’s disease is still a challenge, particularly in its earliest stages, but a new study suggests that subtle changes in behaviour whilst driving could serve as an early warning system. The researchers used GPS logging devices and machine learning as “digital biomarkers” to compare the driving of people who have preclinical Alzheimer’s but are …

How’s my driving? GPS tracking spots Alzheimer’s with 86% accuracy Read More »

physIQ licenses virtual trial tech to Janssen in multi-year deal

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. Janssen will be able to scale up use of Chicago-based physIQ’s biosensors to support both R&D and commercial activities. The pharma company will use the technology known …

physIQ licenses virtual trial tech to Janssen in multi-year deal Read More »

Limited access to cancer biomarker testing in Europe, report finds

There is limited access to biomarker testing for cancer in Europe, despite the huge potential of the technology to improve outcomes, according to a new report. The report from European Federation of Pharmaceutical Industries and Associations (EFPIA) shows the results of research conducted in 2020 to assess the availability, quality and reimbursement of biomarker tests …

Limited access to cancer biomarker testing in Europe, report finds Read More »